Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Nephros (NEPH) Short-Term Debt issuances (2017 - 2020)

Nephros' quarterly Short-Term Debt issuances came in at -$495000.0 in Q2 2020, down 530.43% year-on-year from $115000.0 in Q3 2019, and down 661.54% quarter-over-quarter from -$65000.0 in Q1 2020.

Nephros has reported Short-Term Debt issuances for 4 years, with the latest figure at -$495000.0 in Q2 2020.

  • For the quarter ending Q2 2020, Short-Term Debt issuances fell 530.43% year-over-year to -$495000.0; the trailing twelve-month figure through Jun 2020 stood at -$530000.0 (down 161.06% YoY), and the FY2019 full-year result was -$431000.0, down 253.93% from the prior year.
  • Short-Term Debt issuances for Q2 2020 stood at -$495000.0, down from -$65000.0 in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $828000.0 in Q4 2018, with the low at -$561000.0 in Q1 2018.
  • Average Short-Term Debt issuances over 4 years is -$11333.3, with a median of $3000.0 recorded in 2018.
  • Year-over-year, Short-Term Debt issuances surged 3733.33% in 2019 and tumbled 530.43% in 2020.
  • Tracing NEPH's Short-Term Debt issuances over 4 years: stood at $148000.0 in 2017, then jumped by 459.46% to $828000.0 in 2018, then sank by 86.11% to $115000.0 in 2019, then plunged by 530.43% to -$495000.0 in 2020.
  • The last three Short-Term Debt issuances figures came in at -$495000.0 (Q2 2020), -$65000.0 (Q1 2020), and $115000.0 (Q2 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 11.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 22.00 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 7.00 Mn
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 -495,000.00
Jun 30, 2020 -495,000.00
Mar 31, 2020 -65,000.00
Mar 31, 2020 -65,000.00
Jun 30, 2019 115,000.00
Jun 30, 2019 115,000.00
Mar 31, 2019 -85,000.00
Mar 31, 2019 -85,000.00
Dec 31, 2018 828,000.00
Dec 31, 2018 828,000.00
Sep 30, 2018 10,000.00
Sep 30, 2018 10,000.00
Jun 30, 2018 3,000.00
Jun 30, 2018 3,000.00
Mar 31, 2018 -561,000.00
Mar 31, 2018 -561,000.00
Dec 31, 2017 148,000.00
Dec 31, 2017 148,000.00